Skip to main navigation
Lineage Cell Therapeutics
  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Pipeline
    • Overview
    • OpRegen® for Dry AMD
    • OPC1
    • VAC2
  • Technology
    • Lineage Platform
    • Manufacturing
  • Media
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxy Information
      • 2018 AgeX and Form 10 Information Statement
      • 2019 Form 8937
    • E-mail Alerts
    • Contact IR
  • Menu

Annual Reports

Investor Relations

  • Investors Overview
  • Press Releases
  • Events and Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Financials & Filings
    • SEC Filings
    • Annual Report and Proxy Information
    • 2018 AgeX Form 10 and Information Statement
    • 2019 Form 8937
  • E-mail Alerts
  • Contact IR

Annual Reports

Annual Reports

Filing date Form
Mar 30, 2001 10-K
Annual Shareholder Meeting Proxy Materials
Notice & Proxy Statement
© Copyright - Lineage Cell Therapeutics, Inc.   |   Terms of Use & Privacy   |   contact@lineagecell.com
  • Facebook
  • Twitter
  • RSS Feed
  • Email Alerts
Scroll to top